DTaP-IPV vaccine
DTaP-IPV vaccine is a combination vaccine whose full generic name is diphtheria and tetanus toxoids and acellular pertussis adsorbed and inactivated poliovirus vaccine (IPV).[1]
 DPT-IPV vaccine in Japan | |
| Combination of | |
|---|---|
| DTaP vaccine | Vaccine |
| Inactivated poliovirus vaccine | Vaccine |
| Clinical data | |
| Trade names | Kinrix, Quadracel, Boostrix-IPV, Infanrix-IPV, others |
| Other names | diphtheria, tetanus, pertussis (acellular, component) and poliomyelitis (inactivated) vaccine (adsorbed, reduced antigen(s) content) |
| AHFS/Drugs.com | Kinrix Quadracel |
| Routes of administration | Intramuscular injection |
| ATC code | |
| Legal status | |
| Legal status |
|
It is also known as DTaP/IPV, dTaP/IPV, DTPa-IPV, or DPT-IPV.[1] It protects against the infectious diseases diphtheria, tetanus, pertussis, and poliomyelitis.[1]
Branded formulations marketed in the USA are Kinrix from GlaxoSmithKline[2] and Quadracel from Sanofi Pasteur.[3]
References
- "Diphtheria, Tetanus, Pertussis (Acellular, Component) And Poliomyelitis (Inactivated) Vaccine (Adsorbed)". Drugs.com. Retrieved 15 July 2018.
- "Kinrix". US Food and Drug Administration. Retrieved 15 July 2018.
- "Quadracel". US Food and Drug Administration. Retrieved 15 July 2018.
- "Repevax, suspension for injection, in pre-filled syringe - Summary of Product Characteristics (SmPC) - (emc)". www.medicines.org.uk. Retrieved 31 December 2020.
- "14. Vaccines". British National Formulary (BNF) (80 ed.). BMJ Group and the Pharmaceutical Press. September 2020 – March 2021. p. 1381. ISBN 978-0-85711-369-6.CS1 maint: date format (link)
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.